Skip to main content

Welcome!

The David Laboratory

Home

We study the mechanisms of chronic kidney disease progression and CKD-associated bone/mineral outcomes. We focus on the regulation and function of the bone secreted hormone FGF23 and its interplay with inflammation and iron metabolism.

About Us

Research

Research

We are interested in defining novel modifiable mechanisms of kidney, bone and cardiovascular diseases.

Learn more
Environment

Environment

The David Lab is located on the downtown Chicago Medical campus in the Division of Nephrology and Hypertension and is also affiliated with the Center for Translational Metabolism (CTMH) and Health and the Feinberg Cardiovascular and Renal Research Institute (FCVRRI).

Our Team
Training

Training

Our multicultural and diverse team of investigators is actively engaged in training the next generation of scientists at all levels.

Join Us

Recent Publications

Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease

Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease

Simultaneous management of disordered phosphate and iron homeostasis to correct FGF23 and associated outcomes in CKD

Simultaneous management of disordered phosphate and iron homeostasis to correct FGF23 and associated outcomes in CKD

Transcriptomics: a Solution for Renal Osteodystrophy?

Transcriptomics: a Solution for Renal Osteodystrophy?

Ferric citrate reduces FGF23 levels and improves renal and cardiac function in a mouse model of CKD

Ferric citrate reduces FGF23 levels and improves renal and cardiac function in a mouse model of CKD

Sponsors

Our work is generously supported by the National Institutes of Health (NIH) and the National  Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

We have also received funding from the American Heart Association and from diverse pharmaceuticals companies including  Akebia Therapeutics and Vifor.

Principal Investigator

Valentin David, PhD, MSc

Valentin David, PhD, MSc

Frank Krumlovsky, MD, Professor
Associate Professor of Medicine

Dr. David’s research investigates the causes and consequences of disordered mineral metabolism in chronic kidney disease. The general focus of his lab is the regulation and function of the bone secreted hormone Fibroblast Growth Factor 23 (FGF23) with emphasis on iron metabolism and systemic/local inflammation. He has established multiple national and international collaborations, which includes clinicians to perform bench to bedside science. He is Principal Investigator and co-Investigator on multiple NIH-funded projects, and an active member of the American Society for Bone and Mineral Research and American Society of Nephrology.